Literature DB >> 32130331

Factors associated with tuberculosis and multidrug-resistant tuberculosis in patients treated at a tertiary referral hospital in the state of Minas Gerais, Brazil.

Valéria Martins Soares1, Isabela Neves de Almeida2, Lida Jouca de Assis Figueredo2, João Paulo Amaral Haddad3, Camila Stefanie Fonseca de Oliveira3, Wânia da Silva Carvalho4, Silvana Spindola de Miranda2.   

Abstract

OBJECTIVE: To evaluate the risk factors for the development of tuberculosis and multidrug-resistant tuberculosis (MDR-TB) in patients treated at a tertiary referral hospital.
METHODS: This was a cross-sectional study based on data obtained from patients treated at the Júlia Kubitschek Hospital, located in the city of Belo Horizonte, Brazil, between October of 2012 and October of 2014. We evaluated sociodemographic, behavioral, clinical, and radiological variables. The outcome considered to identify associations between tuberculosis and the explanatory variables was the treatment prescribed. To evaluate the associations between MDR-TB and the same explanatory variables, the change in MDR-TB treatment was considered.
RESULTS: The factors associated with tuberculosis were alcoholism, comorbidities, pulmonary cavitations, and a radiological pattern suggestive of tuberculosis. Cavitation and previous treatment for tuberculosis were associated with MDR-TB.
CONCLUSIONS: Despite the significant progress made in the fight against tuberculosis, there is a need for coordinated actions that include social protection measures and patient support.

Entities:  

Year:  2020        PMID: 32130331     DOI: 10.36416/1806-3756/e20180386

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  1 in total

1.  Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update.

Authors:  Arival Cardoso de Brito; Clivia Maria Moraes de Oliveira; Deborah Aben-Athar Unger; Maraya de Jesus Semblano Bittencourt
Journal:  An Bras Dermatol       Date:  2022-01-04       Impact factor: 2.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.